Home › Imaxio Signs Option for License Agreement to Develop Veterinary Vaccines
 

Keywords :   


Imaxio Signs Option for License Agreement to Develop Veterinary Vaccines

2013-06-12 02:00:00| ThePigSite - Industry News

FRANCE - Imaxio, a biopharmaceutical company specialized in vaccines and genomics, announced that it has signed a license option agreement with Merial, a major animal health laboratory, a top ten company globally in its sector. The aim of the agreement is to develop a number of veterinary vaccines using Imaxio's immuno-enhancing IMX313 technology.

Tags: agreement license option develop

Category:Agriculture and Forestry

Latest from this category

All news
24.09NutriQuest, Modulant Biosciences partner to advance PRRS, swine disease research
24.09Trump threatens to impose 200% tariffs on John Deere
24.09FAPRI report shows mixed bag for U.S. agriculture
24.09APHIS launches new animal disease preparedness, response projects dashboard
24.09Keeping swine facilities safe and functional
24.09Farm Progress America, September 24, 2024
24.09Farm Progress America, September 24, 2024
23.09Stockmanship & Stewardship goes virtual
Agriculture and Forestry »
24.09PPG Announces Executive Leadership Changes
24.09GB Energy: What does it mean for Scotland?
24.09MPS Systems partners with imPRESSions Worldwide
24.09Major Trade Associations to Explore Strategic Alliance
24.09Bulk Exchange Links Waste Management Pros With Construction Project Contractors
24.09Catalyze Completes 4.8 MW Community Solar Project in Frankfort, NY
24.09NutriQuest, Modulant Biosciences partner to advance PRRS, swine disease research
24.09Waste Eliminator Expands Services in Georgia with Acquisition of Unlimited Disposal
More »